AbinscienceELISA其它型号产品
| Stability and Storage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Detection method | Colorimetric |
| Sample type | Plasma, Serum |
| Assay type | Quantitative |
| Sensitivity | 0.156 μg/ml |
| Range | 0.31-5 μg/mL |
| Recovery | 80-120% |
| Background | Mirzotamab clezutoclax (ABBV-155) is a first-in-class antibody drug conjugate comprised of a BCL-X L (B-cell lymphoma - extra long) inhibitor, solubilizing linker, and a monoclonal anti-B7H3 antibody. Methods: Patients (pts) with relapsed and/or refractory (R/R) solid tumors were administered mirzotamab clezutoclax with or without paclitaxel. Dose escalation of mirzotamab clezutoclax was guided by Bayesian continual reassessment. |
| Alternative Names | ABBV-155, CAS: 2229859-11-2 |
| Shipping | 2-8 ℃ |
| Specifications | Mirzotamab |
| Note | For Research Use Only. |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
询价
询价
询价
询价
询价
¥ 10253.00
询价
询价
询价
询价
询价
询价
询价
询价
询价
询价
询价
询价
¥ 14985.93
询价
微信小程序
7X24小时在线咨询